FDA Approves Test for Hematologic Cancer Detection
The FDA has authorized ClearLLabs Reagents to market its test for use with flow cytometry to detect hematologic cancers, including myeloproliferative disorders.
Hematol News
In The News
American Journal of Managed Care
In The Literature
American Journal of Hematology European Journal of Haematology